News tagged with national cancer institute

An old drug finds a new use

Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They ...

Sep 27, 2012
popularity not rated yet | comments 0

Major cancer protein amplifies global gene expression

Scientists may have discovered why a protein called MYC can provoke a variety of cancers. Like many proteins associated with cancer, MYC helps regulate cell growth. A study carried out by researchers at the National Institutes ...

Sep 27, 2012
popularity not rated yet | comments 0 | with audio podcast

AIDS patients face risk for esophageal, stomach cancers

People with AIDS are at increased risk for developing esophageal and stomach carcinoma as well as non-Hodgkin lymphomas (NHLs), according to a new study in Gastroenterology, the official journal of the American Gastroenterological Associ ...

Sep 24, 2012
popularity not rated yet | comments 0

Fighting melanoma's attraction to the brain

(Medical Xpress)—The process of metastasis, by which cancer cells travel from a tumor site and proliferate at other sites in the body, is a serious threat to cancer patients. According to the National Cancer ...

Sep 19, 2012
popularity not rated yet | comments 0 | with audio podcast

Rare cancers yield potential source of tumor growth

(Medical Xpress)—Researchers at the National Institutes of Health have discovered a genetic mutation that appears to increase production of red blood cells in tumors. The discovery, based on analysis of tissue from rare ...

Sep 18, 2012
popularity not rated yet | comments 0 | with audio podcast

Long-term finasteride doesn't impair quality of life

(HealthDay)—Taking finasteride to prevent prostate cancer does not negatively affect the physical function, mental health, or vitality domains of health-related quality of life, according to a study published ...

Sep 13, 2012
popularity 5 / 5 (1) | comments 0